Medline Inc's stock plummeted 5.02% during intraday trading on Friday, extending its recent decline as the company faces multiple headwinds despite reporting strong quarterly results.

The medical supply company's shares came under pressure after Bernstein cut its price target on Medline Inc to $54 from $56, signaling reduced confidence in the stock's near-term prospects. This analyst action contributed to the selling pressure during the trading session.

Additionally, the stock has been experiencing a classic "sell-the-news" pattern following its better-than-expected Q1 earnings report. Despite beating both earnings and revenue estimates, investors have been taking profits, leading to sustained selling pressure over multiple sessions since the earnings announcement.